肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

肿瘤抑制microRNA-551b-3p靶向H6PD抑制胆囊癌进展

Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression 

原文发布日期:2020-11-29 

英文摘要:

摘要翻译: 

原文链接:

文章:

肿瘤抑制microRNA-551b-3p靶向H6PD抑制胆囊癌进展

Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression 

原文发布日期:2020-11-29 

英文摘要:

Gallbladder cancer (GBC) is a highly malignant cancer with poor prognosis. Extensive studies have reported the vital functionality of several microRNAs (miRNAs) in numerous human cancers, including GBC. Microarray analysis has identified the differentially expressed miR-551b-3p in GBC. Therefore, this study aims to validate the underlying mechanism by which miR-551b-3p participated in epithelial–mesenchymal transition (EMT), invasion and migration of GBCs. Bioinformatic analysis predicted the binding of miR-551b-3p to H6PD. We validated the reduced miR-551b-3p expression and increased H6PD expression in the GBC tissues and GBC cell lines. Artificial modulation of miR-551b-3p and H6PD (down- and upregulation) was conducted to explore their roles in EMT, invasive, and migratory abilities of GBCs, and the tumor-bearing mice were used to determine tumor growth. Overexpression of miR-551b-3p or silencing of H6PD was observed to suppress the expressions of N-cadherin and vimentin, and to promote the expression of E-cadherin, along with reduced invasive and migratory ability of GBCs. Mechanistically, miR-551b-3p could evidently target and inhibit the expression of H6PD. Moreover, in vivo experiments substantiated the tumor-inhibiting activities of miR-551b-3p in nude mice. Conjointly, our study suggests that overexpression of miR-551b-3p inhibited the EMT, migration, and invasion of GBCs by inhibiting the expression of H6PD, indicating that miR-551b-3p may serve as a potential target for future development of therapeutic strategies for GBC. 

摘要翻译: 

胆囊癌(GBC)是一种恶性程度高且预后较差的癌症。大量研究报道了多种microRNA(miRNA)在包括GBC在内的多种人类癌症中的重要作用。微阵列分析发现miR-551b-3p在GBC中存在差异性表达。因此,本研究旨在验证miR-551b-3p参与GBC上皮间质转化(EMT)、侵袭和迁移的潜在机制。生物信息学分析预测miR-551b-3p可与H6PD结合。我们证实了GBC组织和GBC细胞系中miR-551b-3p表达降低而H6PD表达升高。通过人工调控miR-551b-3p和H6PD(下调和上调)来探索它们在GBC的EMT、侵袭和迁移能力中的作用,并使用荷瘤小鼠检测肿瘤生长。研究发现过表达miR-551b-3p或沉默H6PD可抑制N-钙黏蛋白和波形蛋白的表达,并促进E-钙黏蛋白的表达,同时降低GBC的侵袭和迁移能力。从机制上讲,miR-551b-3p能够明显靶向并抑制H6PD的表达。此外,体内实验证实了miR-551b-3p在裸鼠中的肿瘤抑制活性。我们的研究表明,过表达miR-551b-3p通过抑制H6PD的表达来抑制GBC的EMT、迁移和侵袭,表明miR-551b-3p可能作为未来开发GBC治疗策略的潜在靶点。

原文链接:

Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……